ATE550426T1 - Polypeptide zur auslösung einer immunreaktion gegen krebs - Google Patents

Polypeptide zur auslösung einer immunreaktion gegen krebs

Info

Publication number
ATE550426T1
ATE550426T1 AT07105178T AT07105178T ATE550426T1 AT E550426 T1 ATE550426 T1 AT E550426T1 AT 07105178 T AT07105178 T AT 07105178T AT 07105178 T AT07105178 T AT 07105178T AT E550426 T1 ATE550426 T1 AT E550426T1
Authority
AT
Austria
Prior art keywords
polypeptides
against cancer
triggering
immune response
response against
Prior art date
Application number
AT07105178T
Other languages
English (en)
Inventor
Gustav Gaudernack
Stein Seboe-Larssen
Mona Moller
Jon Amund Eriksen
Original Assignee
Gemvax As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9905720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE550426(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gemvax As filed Critical Gemvax As
Application granted granted Critical
Publication of ATE550426T1 publication Critical patent/ATE550426T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
AT07105178T 2000-12-22 2001-12-18 Polypeptide zur auslösung einer immunreaktion gegen krebs ATE550426T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0031430.2A GB0031430D0 (en) 2000-12-22 2000-12-22 Polypeptides

Publications (1)

Publication Number Publication Date
ATE550426T1 true ATE550426T1 (de) 2012-04-15

Family

ID=9905720

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01272392T ATE358716T1 (de) 2000-12-22 2001-12-18 Polypeptide zur auslösung einer immunreaktion gegen krebs
AT07105178T ATE550426T1 (de) 2000-12-22 2001-12-18 Polypeptide zur auslösung einer immunreaktion gegen krebs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01272392T ATE358716T1 (de) 2000-12-22 2001-12-18 Polypeptide zur auslösung einer immunreaktion gegen krebs

Country Status (14)

Country Link
US (4) US7078416B2 (de)
EP (3) EP2361978B1 (de)
JP (3) JP2004522433A (de)
AT (2) ATE358716T1 (de)
AU (3) AU2002216477B2 (de)
CA (2) CA2782510C (de)
CY (2) CY1106564T1 (de)
DE (1) DE60127715T2 (de)
DK (3) DK2361978T3 (de)
ES (2) ES2280311T3 (de)
GB (1) GB0031430D0 (de)
NO (2) NO332137B1 (de)
PT (2) PT1862544E (de)
WO (1) WO2002051994A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
WO2001060391A1 (en) * 2000-02-15 2001-08-23 Regents Of The University Of California A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
US7439042B2 (en) * 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
CN104147597A (zh) * 2002-12-16 2014-11-19 全球免疫股份有限公司 用于免疫治疗的基于酵母的疫苗
US8343502B2 (en) * 2002-12-16 2013-01-01 Globeimmune, Inc. Yeast-based vaccines as immunotherapy
EP1601684B1 (de) 2003-03-05 2014-10-15 Dendreon Corporation Zusammensetzungen und verfahren unter anwendung von polypeptiden mit alternativem leserahmen zur behandlung von krebs und infektionskrankheiten
WO2006044923A2 (en) * 2004-10-18 2006-04-27 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis c infection
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
EP2331125A4 (de) 2008-09-19 2013-03-27 Globeimmune Inc Immuntherapie zur für chronische hepatitis-c-virus-infektionen
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
CN110709094A (zh) 2017-02-03 2020-01-17 威斯康星州医药大学股份有限公司 Kras肽疫苗组合物及其使用方法
US20200276285A1 (en) 2017-06-02 2020-09-03 Arizona Board Of Regents On Behalf Of Arizona State University A method to create personalized cancer vaccines
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
EP4038222A4 (de) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University Verfahren und zusammensetzungen zur identifizierung von neoantigenen zur verwendung bei der behandlung und vorbeugung von krebs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803070A (en) 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
GB9103974D0 (en) 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
EP0917579A1 (de) * 1997-07-01 1999-05-26 Cambia Biosystems LLC Gene und proteine von vertebraten telomerasen, und deren verwendungen
EP1068296B1 (de) 1998-03-31 2011-08-10 Geron Corporation Zusammensetzungen zur auslösung einer immunantwort gegen ein telomerase antigen
WO1999050932A1 (fr) * 1998-03-31 1999-10-07 Matsushita Electric Industrial Co., Ltd. Antenne et televiseur numerique
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
NO315238B1 (no) 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
US7030211B1 (en) 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
WO2000061766A2 (en) * 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine
EP1259812A2 (de) 1999-05-28 2002-11-27 Ludwig Institute For Cancer Research Mit brust-, magen- und prostatakrebs in verbindung stehende antigene und deren verwendung
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides

Also Published As

Publication number Publication date
AU2007211889C1 (en) 2010-06-10
EP2361978A1 (de) 2011-08-31
DE60127715T2 (de) 2007-12-27
AU2007211889B2 (en) 2009-11-19
US20080187551A1 (en) 2008-08-07
WO2002051994A3 (en) 2002-12-27
AU2007211889A1 (en) 2007-09-13
NO332137B1 (no) 2012-07-02
EP1352056B1 (de) 2007-04-04
WO2002051994A2 (en) 2002-07-04
JP2012080883A (ja) 2012-04-26
AU2002216477B2 (en) 2007-05-24
NO20110429L (no) 2003-08-21
NO20032818D0 (no) 2003-06-19
US8193326B2 (en) 2012-06-05
CA2782510A1 (en) 2002-07-04
AU2010200620B2 (en) 2012-11-01
CA2782510C (en) 2014-07-15
AU2002216477C1 (en) 2002-07-08
PT1352056E (pt) 2007-05-31
US20120269858A1 (en) 2012-10-25
DK1862544T3 (da) 2012-07-09
US7078416B2 (en) 2006-07-18
CY1106564T1 (el) 2012-01-25
JP2004522433A (ja) 2004-07-29
ES2280311T3 (es) 2007-09-16
DK1352056T3 (da) 2007-05-29
JP2014138587A (ja) 2014-07-31
US20060194731A1 (en) 2006-08-31
EP1352056A2 (de) 2003-10-15
EP1862544A1 (de) 2007-12-05
AU2010200620A1 (en) 2010-03-11
CA2432971C (en) 2012-09-04
GB0031430D0 (en) 2001-02-07
NO20032818L (no) 2003-08-21
EP1862544B1 (de) 2012-03-21
US7375117B2 (en) 2008-05-20
ES2382821T3 (es) 2012-06-13
ATE358716T1 (de) 2007-04-15
EP2361978B1 (de) 2015-10-14
DK2361978T3 (en) 2016-01-25
CY1112735T1 (el) 2016-02-10
WO2002051994A8 (en) 2003-03-06
CA2432971A1 (en) 2002-07-04
AU2007211889B8 (en) 2009-12-10
EP1862544B2 (de) 2016-03-09
DE60127715D1 (de) 2007-05-16
NO342257B1 (no) 2018-04-30
PT1862544E (pt) 2012-05-07
US20040072759A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
NO20110429L (no) Polypeptider og nukleinsyre-DNA for anvendelse innen medisin
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE386800T1 (de) Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
ATE315088T1 (de) Tumorassoziierte antigenderivate der mage-familie,nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
WO2002080851A3 (en) Chimeric vaccines
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
EP1289551A4 (de) HUMANE POLYPEPTIDE WELCHE ZUM ABSTERBEN VON ZELLEN, INSBESONDERE LYMPHOIDER TUMORZELLEN, FüHREN
WO2000034317A3 (en) Method for reducing immunogenicity of proteins
WO1997048370A3 (en) Vaccines comprising synthetic genes
ATE410446T1 (de) Zusammensetzungen zur behandlung und diagnose von eierstockkrebs
AU5810201A (en) Immunogenic polypeptides encoded by mage minigenes and uses thereof
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
ATE229977T1 (de) Peptide mit antiproliferativen eigenschaften
WO2001005825A3 (en) Nucleic acid sequences encoding putative angiopoietin proteins
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2005007673A3 (en) Immunogenic peptides
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
WO2001074845A3 (en) Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
WO2003093298A3 (en) Immunogenic peptides
EP1731611A3 (de) Eimeria hydrophile Polypeptide, ihre Verwendung in Impstoffen
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
UY26588A1 (es) Mutantes de ehv gm-negativos
AU1572702A (en) Novel immunomodulatory protein and useful embodiments thereof